Literature DB >> 7609084

Proviral activation of the c-myb proto-oncogene is detectable in preleukemic mice infected neonatally with Moloney murine leukemia virus but not in resulting end stage T lymphomas.

B Belli1, L Wolff, V Nazarov, H Fan.   

Abstract

Moloney murine leukemia virus induces myeloid leukemia when inoculated intravenously into pristane-primed adult BALB/c mice. One hundred percent of these tumors show insertional activation of the c-myb proto-oncogene, and reverse transcriptase PCR assays have shown that the c-myb activation could be detected soon after infection. We tested BALB/c and NIH Swiss mice that had been inoculated as newborns with Moloney murine leukemia virus, under which conditions they develop T lymphomas exclusively. Reverse transcriptase-PCR assays indicated that c-myb activations were detectable soon after neonatal infection. However, none of the resulting T lymphomas contained c-myb activations. The implications of these results to the timing of proto-oncogene activations in leukemogenesis and the specificity of proto-oncogene activations for different diseases are discussed.

Entities:  

Mesh:

Year:  1995        PMID: 7609084      PMCID: PMC189334          DOI: 10.1128/JVI.69.8.5138-5141.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  13 in total

1.  Moloney murine leukemia virus-induced myeloid tumors in adult BALB/c mice: requirement of c-myb activation but lack of v-abl involvement.

Authors:  G L Shen-Ong; L Wolff
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Bone marrow depletion by 89Sr complements a preleukemic defect in a long terminal repeat variant of Moloney murine leukemia virus.

Authors:  Q X Li; H Fan
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Characterization of lymphoid tumors induced by a recombinant murine retrovirus carrying the avian v-myc oncogene. Identification of novel (B-lymphoid) tumors in the thymus.

Authors:  B K Brightman; K G Chandy; R H Spencer; S Gupta; P K Pattengale; H Fan
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

4.  Early clonality and high-frequency proviral integration into the c-myc locus in AKR leukemias.

Authors:  P V O'Donnell; E Fleissner; H Lonial; C F Koehne; A Reicin
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

5.  Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis.

Authors:  W S Hayward; B G Neel; S M Astrin
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

6.  An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo.

Authors:  B K Brightman; A Rein; D J Trepp; H Fan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

7.  Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region.

Authors:  H T Cuypers; G Selten; W Quint; M Zijlstra; E R Maandag; W Boelens; P van Wezenbeek; C Melief; A Berns
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

8.  Characterization of a preleukemic state induced by Moloney murine leukemia virus: evidence for two infection events during leukemogenesis.

Authors:  B R Davis; B K Brightman; K G Chandy; H Fan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

9.  Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.

Authors:  V Nazarov; D Hilbert; L Wolff
Journal:  Virology       Date:  1994-12       Impact factor: 3.616

10.  A chronic inflammatory response. Its role in supporting the development of c-myb and c-myc related promonocytic and monocytic tumors in BALB/c mice.

Authors:  L Wolff; J F Mushinski; G L Shen-Ong; H C Morse
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

View more
  6 in total

1.  A virus-virus interaction circumvents the virus receptor requirement for infection by pathogenic retroviruses.

Authors:  David L Wensel; Weihua Li; James M Cunningham
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Retroviral insertional activation of the c-myb proto-oncogene in a Marek's disease T-lymphoma cell line.

Authors:  E Le Rouzic; B Perbal
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Differential selection of cells with proviral c-myc and c-erbB integrations after avian leukosis virus infection.

Authors:  M Gong; H L Semus; K J Bird; B J Stramer; A Ruddell
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

4.  A retroviral mutagenesis screen identifies Cd74 as a common insertion site in murine B-lymphomas and reveals the existence of a novel IFNgamma-inducible Cd74 isoform.

Authors:  Magdalena Pyrz; Bruce Wang; Matthias Wabl; Finn Skou Pedersen
Journal:  Mol Cancer       Date:  2010-04-23       Impact factor: 27.401

5.  Long-range effects of retroviral insertion on c-myb: overexpression may be obscured by silencing during tumor growth in vitro.

Authors:  L Hanlon; N I Barr; K Blyth; M Stewart; P Haviernik; L Wolff; K Weston; E R Cameron; J C Neil
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 6.  Insertional oncogenesis by non-acute retroviruses: implications for gene therapy.

Authors:  Hung Fan; Chassidy Johnson
Journal:  Viruses       Date:  2011-04-15       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.